We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$245M
AUM Growth
+$6.42M
Cap. Flow
+$10.6M
Cap. Flow %
4.35%
Top 10 Hldgs %
74.43%
Holding
71
New
8
Increased
23
Reduced
20
Closed
3

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$3.19M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$2.07M
3
BND icon
Vanguard Total Bond Market
BND
+$2.06M
4
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$1.63M
5
FNDB icon
Schwab Fundamental US Broad Market Index ETF
FNDB
+$1.33M

Top Sells

Rank Stock Value
1
SCHB icon
Schwab US Broad Market ETF
SCHB
+$1.46M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$742K
3
NBIX icon
Neurocrine Biosciences
NBIX
+$322K
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$279K
5
RMD icon
ResMed
RMD
+$263K

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.18%
2 Healthcare 12.42%
3 Real Estate 0.47%
4 Financials 0.35%
5 Materials 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
51
Tesla
TSLA
$1.38T
$278K 0.11%
19,650
-3,750
-16% -$56.8K
CTLT
52
DELISTED
CATALENT, INC.
CTLT
$269K 0.11%
+11,700
New +$309K
DLN icon
53
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$260K 0.11%
6,872
-648
-9% -$24K
EPP icon
54
iShares MSCI Pacific ex Japan ETF
EPP
$2.32B
$248K 0.1%
6,330
+998
+19% +$39.1K
ILMN icon
55
Illumina
ILMN
$32.6B
$242K 0.1%
1,772
+41
+2% +$5.82K
VWO icon
56
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$241K 0.1%
6,832
-5,065
-43% -$173K
IVV icon
57
iShares Core S&P 500 ETF
IVV
$898B
$215K 0.09%
1,020
– –
PPBI
58
DELISTED
Pacific Premier Bancorp
PPBI
$213K 0.09%
+8,862
New +$206K
ASRT
59
DELISTED
Assertio
ASRT
$210K 0.09%
178
– –
WMAR
60
DELISTED
West Marine Inc
WMAR
$169K 0.07%
+20,200
New +$186K
SQNM
61
DELISTED
SEQUENOM INC NEW
SQNM
$162K 0.07%
176,777
– –
HNGR
62
DELISTED
Hanger Inc.
HNGR
$155K 0.06%
20,836
– –
BAC icon
63
Bank of America
BAC
$436B
$133K 0.05%
10,009
– –
CDTX
64
DELISTED
Cidara Therapeutics
CDTX
$122K 0.05%
+593
New +$144K
APTO
65
DELISTED
Aptose Biosciences, Inc.
APTO
$29K 0.01%
27
– –
SEEL
66
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
BIOC
67
DELISTED
Biocept, Inc.
BIOC
$25K 0.01%
1
– –
ARNA
68
DELISTED
Arena Pharmaceuticals Inc
ARNA
$21K 0.01%
+1,200
New +$21.5K
DBEF icon
69
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.38B
– –
-10,918
Closed -$279K
IWB icon
70
iShares Russell 1000 ETF
IWB
$49.1B
– –
-2,157
Closed -$246K
RGLS
71
DELISTED
Regulus Therapeutics
RGLS
– –
-238
Closed -$198K
1 2
3

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Callan Capital held 71 positions worth $245M, up 2.7% from $239M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Callan Capital deployed $10.6M of net new capital in Q2 2016, opening 8 new positions and adding to 23 existing holdings. Its largest new stake was Schwab Fundamental US Broad Market Index ETF: 134,202 shares worth $1.34M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 83% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Schwab US Broad Market ETF, an estimated $1.46M trimmed.

  • Callan Capital's largest Q2 2016 buy was Schwab Fundamental US Broad Market Index ETF: 134,202 shares worth $1.34M.
  • Callan Capital added most to Vanguard Short-Term Corporate Bond ETF in Q2 2016, an estimated $3.19M increase.
  • Callan Capital's biggest Q2 2016 reduction was Schwab US Broad Market ETF, cutting an estimated $1.46M.
  • Callan Capital fully exited Xtrackers MSCI EAFE Hedged Equity ETF in Q2 2016, selling an estimated $279K.
  • Callan Capital's ten largest holdings make up 74% of its $245M portfolio in Q2 2016.
  • Callan Capital opened 8 new positions and closed 3 in Q2 2016.
  • Callan Capital's portfolio value rose 2.7% quarter-over-quarter to $245M.

Based on Callan Capital's 13F filing for Q2 2016, filed 12 Aug 2016.